Ticker Details
Recursion Pharmaceuticals, Inc.
IPO Date:	April 16, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.78B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.41 | 3.87%
Avg Daily Range (30 D):	$0.15 | 3.79%
Avg Daily Range (90 D):	$0.17 | 3.68%

Institutional Daily Volume
Avg Daily Volume:	8.52M
Avg Daily Volume (30 D):	20.13M
Avg Daily Volume (90 D):	30.69M

Trade Size
Avg Trade Size (Sh.):	241
Avg Trade Size (Sh.) (30 D):	345
Avg Trade Size (Sh.) (90 D):	430

Institutional Trades
Total Institutional Trades:	2,731
Avg Institutional Trade:	$2.26M
Avg Institutional Trade (30 D):	$1.69M
Avg Institutional Trade (90 D):	$2.22M
Avg Institutional Trade Volume:	.3M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.93M
Avg Closing Trade (30 D):	$3.24M
Avg Closing Trade (90 D):	$4.77M
Avg Closing Volume:	524.16K

News

Feb 24, 2026 @ 8:52 PM ARK Unplugged: How Cathie Wood Crushed the S&P 500... Source: Erica Kollmann

Feb 22, 2026 @ 3:02 PM Cathie Wood Goes Bargain Hunting: 3 Stocks She Jus... Source: Rick Munarriz

Jan 29, 2026 @ 2:01 AM Can This Beaten-Down AI Stock Bounce Back in 2026?... Source: Prosper Junior Bakiny

Dec 8, 2025 @ 10:10 PM Why Recursion Pharamaceuticals Topped the Market T... Source: Eric Volkman

Nov 19, 2025 @ 1:13 PM Is Recursion Pharmaceuticals a Meme Stock? Source: Prosper Junior Bakiny

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.36	$-.41	$-.5
Diluted EPS	$-.36	$-.41	$-.5
Revenue	$5.18M	$19.22M	$14.75M
Gross Profit	$-9.51M	$-.94M	$-7.08M
Net Income / Loss	$-162.25M	$-171.9M	$-202.49M
Operating Income / Loss	$-172.2M	$-176.23M	$-191.37M
Cost of Revenue	$14.69M	$20.16M	$21.83M
Net Cash Flow	$133.3M	$24.69M	$-93.87M
PE Ratio